Global Lorlatinib Market Growth 2025-2031

December 2025 | 78 pages | ID: G455B101ADAEN
LP Information

Abstracts

The global Lorlatinib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Lorlatinib is a medication that is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It is used only if your cancer has a specific genetic marker (an abnormal “ALK” gene). Your doctor will test you for this gene. Lorlatinib works by blocking the activity of the ALK protein, which may help to slow or stop the growth of cancer cells. Lorlatinib is taken by mouth as a capsule, usually once a day.

The future market trends of lorlatinib are expected to be positive, as the demand for this product is driven by the increasing prevalence of NSCLC with ALK gene mutations, which account for about 5% of all NSCLCs. Additionally, rising awareness about the benefits of lorlatinib therapy and the development of novel and more potent lorlatinib are also propelling the growth of this market. Some of the factors that may hamper the market growth are the side effects of lorlatinib, such as nausea, diarrhea, and liver damage, and the emergence of resistance mutations that limit the efficacy of lorlatinib.

LP Information, Inc. (LPI) ' newest research report, the “Lorlatinib Industry Forecast” looks at past sales and reviews total world Lorlatinib sales in 2024, providing a comprehensive analysis by region and market sector of projected Lorlatinib sales for 2025 through 2031. With Lorlatinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lorlatinib industry.

This Insight Report provides a comprehensive analysis of the global Lorlatinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lorlatinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lorlatinib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lorlatinib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lorlatinib.

This report presents a comprehensive overview, market shares, and growth opportunities of Lorlatinib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Tables 25mg
• Tables 100mg

Segmentation by Application:

• Squamous Cell Carcinoma of NSCLC
• Adenocarcinoma of NSCLC
• Large Cell Carcinoma of NSCLC

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pfizer

Key Questions Addressed in this Report

What is the 10-year outlook for the global Lorlatinib market?

What factors are driving Lorlatinib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Lorlatinib market opportunities vary by end market size?

How does Lorlatinib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Lorlatinib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Lorlatinib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Lorlatinib by Country/Region, 2020, 2024 & 2031
2.2 Lorlatinib Segment by Type
  2.2.1 Tables 25mg
  2.2.2 Tables 100mg
2.3 Lorlatinib Sales by Type
  2.3.1 Global Lorlatinib Sales Market Share by Type (2020-2025)
  2.3.2 Global Lorlatinib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Lorlatinib Sale Price by Type (2020-2025)
2.4 Lorlatinib Segment by Application
  2.4.1 Squamous Cell Carcinoma of NSCLC
  2.4.2 Adenocarcinoma of NSCLC
  2.4.3 Large Cell Carcinoma of NSCLC
2.5 Lorlatinib Sales by Application
  2.5.1 Global Lorlatinib Sale Market Share by Application (2020-2025)
  2.5.2 Global Lorlatinib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Lorlatinib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Lorlatinib Breakdown Data by Company
  3.1.1 Global Lorlatinib Annual Sales by Company (2020-2025)
  3.1.2 Global Lorlatinib Sales Market Share by Company (2020-2025)
3.2 Global Lorlatinib Annual Revenue by Company (2020-2025)
  3.2.1 Global Lorlatinib Revenue by Company (2020-2025)
  3.2.2 Global Lorlatinib Revenue Market Share by Company (2020-2025)
3.3 Global Lorlatinib Sale Price by Company
3.4 Key Manufacturers Lorlatinib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Lorlatinib Product Location Distribution
  3.4.2 Players Lorlatinib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR LORLATINIB BY GEOGRAPHIC REGION

4.1 World Historic Lorlatinib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Lorlatinib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Lorlatinib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lorlatinib Market Size by Country/Region (2020-2025)
  4.2.1 Global Lorlatinib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Lorlatinib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lorlatinib Sales Growth
4.4 APAC Lorlatinib Sales Growth
4.5 Europe Lorlatinib Sales Growth
4.6 Middle East & Africa Lorlatinib Sales Growth

5 AMERICAS

5.1 Americas Lorlatinib Sales by Country
  5.1.1 Americas Lorlatinib Sales by Country (2020-2025)
  5.1.2 Americas Lorlatinib Revenue by Country (2020-2025)
5.2 Americas Lorlatinib Sales by Type (2020-2025)
5.3 Americas Lorlatinib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Lorlatinib Sales by Region
  6.1.1 APAC Lorlatinib Sales by Region (2020-2025)
  6.1.2 APAC Lorlatinib Revenue by Region (2020-2025)
6.2 APAC Lorlatinib Sales by Type (2020-2025)
6.3 APAC Lorlatinib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Lorlatinib by Country
  7.1.1 Europe Lorlatinib Sales by Country (2020-2025)
  7.1.2 Europe Lorlatinib Revenue by Country (2020-2025)
7.2 Europe Lorlatinib Sales by Type (2020-2025)
7.3 Europe Lorlatinib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Lorlatinib by Country
  8.1.1 Middle East & Africa Lorlatinib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Lorlatinib Revenue by Country (2020-2025)
8.2 Middle East & Africa Lorlatinib Sales by Type (2020-2025)
8.3 Middle East & Africa Lorlatinib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lorlatinib
10.3 Manufacturing Process Analysis of Lorlatinib
10.4 Industry Chain Structure of Lorlatinib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Lorlatinib Distributors
11.3 Lorlatinib Customer

12 WORLD FORECAST REVIEW FOR LORLATINIB BY GEOGRAPHIC REGION

12.1 Global Lorlatinib Market Size Forecast by Region
  12.1.1 Global Lorlatinib Forecast by Region (2026-2031)
  12.1.2 Global Lorlatinib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lorlatinib Forecast by Type (2026-2031)
12.7 Global Lorlatinib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Lorlatinib Product Portfolios and Specifications
  13.1.3 Pfizer Lorlatinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Lorlatinib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Lorlatinib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTables 25mg
Table 4. Major Players ofTables 100mg
Table 5. Global Lorlatinib Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Lorlatinib Sales Market Share by Type (2020-2025)
Table 7. Global Lorlatinib Revenue by Type (2020-2025) & ($ million)
Table 8. Global Lorlatinib Revenue Market Share by Type (2020-2025)
Table 9. Global Lorlatinib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Lorlatinib Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Lorlatinib Sale Market Share by Application (2020-2025)
Table 12. Global Lorlatinib Revenue by Application (2020-2025) & ($ million)
Table 13. Global Lorlatinib Revenue Market Share by Application (2020-2025)
Table 14. Global Lorlatinib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Lorlatinib Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Lorlatinib Sales Market Share by Company (2020-2025)
Table 17. Global Lorlatinib Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Lorlatinib Revenue Market Share by Company (2020-2025)
Table 19. Global Lorlatinib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Lorlatinib Producing Area Distribution and Sales Area
Table 21. Players Lorlatinib Products Offered
Table 22. Lorlatinib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Lorlatinib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Lorlatinib Sales Market Share Geographic Region (2020-2025)
Table 27. Global Lorlatinib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Lorlatinib Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Lorlatinib Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Lorlatinib Sales Market Share by Country/Region (2020-2025)
Table 31. Global Lorlatinib Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Lorlatinib Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Lorlatinib Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Lorlatinib Sales Market Share by Country (2020-2025)
Table 35. Americas Lorlatinib Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Lorlatinib Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Lorlatinib Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Lorlatinib Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Lorlatinib Sales Market Share by Region (2020-2025)
Table 40. APAC Lorlatinib Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Lorlatinib Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Lorlatinib Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Lorlatinib Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Lorlatinib Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Lorlatinib Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Lorlatinib Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Lorlatinib Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Lorlatinib Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Lorlatinib Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Lorlatinib Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Lorlatinib
Table 52. Key Market Challenges & Risks of Lorlatinib
Table 53. Key Industry Trends of Lorlatinib
Table 54. Lorlatinib Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Lorlatinib Distributors List
Table 57. Lorlatinib Customer List
Table 58. Global Lorlatinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Lorlatinib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Lorlatinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Lorlatinib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Lorlatinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Lorlatinib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Lorlatinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Lorlatinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Lorlatinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Lorlatinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Lorlatinib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Lorlatinib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Lorlatinib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Lorlatinib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Lorlatinib Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Lorlatinib Product Portfolios and Specifications
Table 74. Pfizer Lorlatinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Lorlatinib
Figure 2. Lorlatinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lorlatinib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Lorlatinib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Lorlatinib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Lorlatinib Sales Market Share by Country/Region (2024)
Figure 10. Lorlatinib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTables 25mg
Figure 12. Product Picture ofTables 100mg
Figure 13. Global Lorlatinib Sales Market Share by Type in 2025
Figure 14. Global Lorlatinib Revenue Market Share by Type (2020-2025)
Figure 15. Lorlatinib Consumed in Squamous Cell Carcinoma of NSCLC
Figure 16. Global Lorlatinib Market: Squamous Cell Carcinoma of NSCLC (2020-2025) & (K Pcs)
Figure 17. Lorlatinib Consumed in Adenocarcinoma of NSCLC
Figure 18. Global Lorlatinib Market: Adenocarcinoma of NSCLC (2020-2025) & (K Pcs)
Figure 19. Lorlatinib Consumed in Large Cell Carcinoma of NSCLC
Figure 20. Global Lorlatinib Market: Large Cell Carcinoma of NSCLC (2020-2025) & (K Pcs)
Figure 21. Global Lorlatinib Sale Market Share by Application (2024)
Figure 22. Global Lorlatinib Revenue Market Share by Application in 2025
Figure 23. Lorlatinib Sales by Company in 2025 (K Pcs)
Figure 24. Global Lorlatinib Sales Market Share by Company in 2025
Figure 25. Lorlatinib Revenue by Company in 2025 ($ millions)
Figure 26. Global Lorlatinib Revenue Market Share by Company in 2025
Figure 27. Global Lorlatinib Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Lorlatinib Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Lorlatinib Sales 2020-2025 (K Pcs)
Figure 30. Americas Lorlatinib Revenue 2020-2025 ($ millions)
Figure 31. APAC Lorlatinib Sales 2020-2025 (K Pcs)
Figure 32. APAC Lorlatinib Revenue 2020-2025 ($ millions)
Figure 33. Europe Lorlatinib Sales 2020-2025 (K Pcs)
Figure 34. Europe Lorlatinib Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Lorlatinib Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Lorlatinib Revenue 2020-2025 ($ millions)
Figure 37. Americas Lorlatinib Sales Market Share by Country in 2025
Figure 38. Americas Lorlatinib Revenue Market Share by Country (2020-2025)
Figure 39. Americas Lorlatinib Sales Market Share by Type (2020-2025)
Figure 40. Americas Lorlatinib Sales Market Share by Application (2020-2025)
Figure 41. United States Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Lorlatinib Sales Market Share by Region in 2025
Figure 46. APAC Lorlatinib Revenue Market Share by Region (2020-2025)
Figure 47. APAC Lorlatinib Sales Market Share by Type (2020-2025)
Figure 48. APAC Lorlatinib Sales Market Share by Application (2020-2025)
Figure 49. China Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 53. India Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Lorlatinib Sales Market Share by Country in 2025
Figure 57. Europe Lorlatinib Revenue Market Share by Country (2020-2025)
Figure 58. Europe Lorlatinib Sales Market Share by Type (2020-2025)
Figure 59. Europe Lorlatinib Sales Market Share by Application (2020-2025)
Figure 60. Germany Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 61. France Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Lorlatinib Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Lorlatinib Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Lorlatinib Sales Market Share by Application (2020-2025)
Figure 68. Egypt Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Lorlatinib Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Lorlatinib in 2025
Figure 74. Manufacturing Process Analysis of Lorlatinib
Figure 75. Industry Chain Structure of Lorlatinib
Figure 76. Channels of Distribution
Figure 77. Global Lorlatinib Sales Market Forecast by Region (2026-2031)
Figure 78. Global Lorlatinib Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Lorlatinib Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Lorlatinib Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Lorlatinib Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Lorlatinib Revenue Market Share Forecast by Application (2026-2031)